Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Access to Radiation Therapy by Syrian Refugees Displaced to Turkey.
Dagoglu N, Karaman S, Atalar B, Miller RC, Oral EN. Dagoglu N, et al. Among authors: atalar b. Adv Radiat Oncol. 2022 Jul 15;7(4):100976. doi: 10.1016/j.adro.2022.100976. eCollection 2022 Jul-Aug. Adv Radiat Oncol. 2022. PMID: 35865370 Free PMC article.
The rare cancer network: ongoing studies and future strategy.
Ozsahin M, Mirimanoff RO, Thariat J, Sun XS, Atalar B, Lassen-Ramshad Y, Ugurluer G, Krishnan S, Hallemeier C, Houtte PV, Krengli M, Zhang LJ, Chang K, Funk R, Rooney J, Miller RC. Ozsahin M, et al. Among authors: atalar b. Rare Tumors. 2014 Aug 8;6(3):5465. doi: 10.4081/rt.2014.5465. eCollection 2014 Jul 30. Rare Tumors. 2014. PMID: 25276326 Free PMC article.
Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar B, Ozsahin M, Call J, Napieralska A, Kamer S, Villa S, Erpolat P, Negretti L, Lassen-Ramshad Y, Onal C, Akyurek S, Ugurluer G, Baumert BG, Servagi-Vernat S, Miller RC, Ozyar E, Sio TT. Atalar B, et al. Radiother Oncol. 2018 Apr;127(1):96-102. doi: 10.1016/j.radonc.2017.12.028. Epub 2018 Jan 17. Radiother Oncol. 2018. PMID: 29373196
Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study.
Sahin B, Atalar B, Kaytan Saglam E, Akgun Z, Abacioglu U, Arifoglu A, Ozyar E, Yaprak G, Ozseker Isik N, Guney Y, Caglar HB, Karaman S, Igdem S, Selek U, Berber T, Oner Dincbas F, Sengoz M, Yucel S, Demiral AN, Akyurek S. Sahin B, et al. Among authors: atalar b. Clin Respir J. 2020 Nov;14(11):1050-1059. doi: 10.1111/crj.13240. Epub 2020 Aug 17. Clin Respir J. 2020. PMID: 32749053
Utilization of radiation therapy and predictors of noncompliance among Syrian refugees in Turkey.
Sayan M, Eren MF, Kilic SS, Kotek A, Kaplan SO, Duran O, Cukurcayır F, Babalıoglu I, Or OD, Ozturk GA, Eroglu C, Teke F, Kurtul N, Kutuk T, Bicakci BC, Senyurek S, Aktan M, Mamidanna S, Ohri N, Haffty B, Atalar B. Sayan M, et al. Among authors: atalar b. BMC Cancer. 2022 May 12;22(1):532. doi: 10.1186/s12885-022-09558-5. BMC Cancer. 2022. PMID: 35550042 Free PMC article.
Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases.
Kutuk T, Herrera R, Mustafayev TZ, Gungor G, Ugurluer G, Atalar B, Kotecha R, Hall MD, Rubens M, Mittauer KE, Contreras JA, McCulloch J, Kalman NS, Alvarez D, Romaguera T, Gutierrez AN, Garcia J, Kaiser A, Mehta MP, Ozyar E, Chuong MD. Kutuk T, et al. Among authors: atalar b. Adv Radiat Oncol. 2022 Apr 25;7(6):100978. doi: 10.1016/j.adro.2022.100978. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 35647412 Free PMC article.
67 results